J Cardiovasc Imaging.  2019 Apr;27(2):156-157. 10.4250/jcvi.2019.27.e15.

A Case of Reversible but Highly Vulnerable Adriamycin-induced Cardiomyopathy: A Multi-modality Imaging Approach

• Jung MH
• Jung JI
• Park SM
• Youn HJ
• Hong KS

• KMID: 2442752
• DOI: http://doi.org/10.4250/jcvi.2019.27.e15

Abstract

No abstract available.

MeSH Terms

Cardiomyopathies*

Figure

• 

  Figure 1 (A) Global longitudinal strain (GLS) at initial presentation (-8.3%). (B) GLS after 3 months of heart failure management (-13.0%). (C) GLS after 6 months of heart failure management (-17.1%). (D) Native T1 mapping of left ventricle (LV) (1,394 msec). (E) Post-contrast T1 mapping of LV (453 msec); extracellular volume was then calculated (32.5%). (F) Late gadolinium enhancement imaging.

Reference

1. Kim H, Chung WB, Cho KI, et al. Diagnosis, treatment, and prevention of cardiovascular toxicity related to anti-cancer treatment in clinical practice: an opinion paper from the working group on Cardio-Oncology of the Korean Society of Echocardiography. J Cardiovasc Ultrasound. 2018; 26:1–25.

2. Schelbert EB, Messroghli DR. State of the art: clinical applications of cardiac T1 mapping. Radiology. 2016; 278:658–676.

3. Hong YJ, Park HS, Park JK, et al. Early detection and serial monitoring of anthracycline-induced cardiotoxicity using T1-mapping cardiac magnetic resonance imaging: an animal study. Sci Rep. 2017; 7:2663.

4. Jordan JH, Vasu S, Morgan TM, et al. Anthracycline-associated T1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors. Circ Cardiovasc Imaging. 2016; 9:e004325.